Marshall Wace, LLP Legend Biotech Corp Transaction History

Marshall Wace, LLP

$81.7 Billion
Q2 2025

A detailed history of Marshall Wace, LLP transactions in Legend Biotech Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 13,683 shares of LEGN stock, worth $506,134. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,683

Previous 380,064 96.4%

Holding current value

$506,134

Previous $12.9 Million 96.24%

% of portfolio

0.0%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$27.69 - $37.91 $10.1 Million - $13.9 Million	-366,381 Reduced 96.4%	13,683 $485,000
Q1 2025 May 15, 2025	BUY	$31.43 - $39.7 $581,517 - $734,529	18,502 Added 5.12%	380,064 $12.9 Million
Q4 2024 Feb 13, 2025	SELL	$32.49 - $50.28 $4.31 Million - $6.68 Million	-132,805 Reduced 26.86%	361,562 $11.8 Million
Q3 2024 Nov 14, 2024	BUY	$43.55 - $59.88 $21.5 Million - $29.6 Million	494,367 New	494,367 $24.1 Million
Q4 2022 Feb 14, 2023	BUY	$38.8 - $55.46 $1.44 Million - $2.06 Million	37,125 New	37,125 $1.85 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $55.0 $4.3 Million - $7.06 Million	-128,290 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$31.02 - $48.18 $8.02 Million - $12.5 Million	-258,583 Reduced 66.84%	128,290 $4.66 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $10.1 Million - $14 Million	245,498 Added 173.65%	386,873 $18 Million
Q2 2021 Aug 13, 2021	BUY	$25.8 - $41.09 $3.04 Million - $4.84 Million	117,753 Added 498.49%	141,375 $5.8 Million
Q1 2021 May 17, 2021	BUY	$23.55 - $32.4 $556,298 - $765,352	23,622 New	23,622 $686,000
Q3 2020 Nov 16, 2020	SELL	$27.5 - $39.61 $346,885 - $499,640	-12,614 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$36.1 - $42.56 $455,365 - $536,851	12,614 New	12,614 $537,000

Others Institutions Holding LEGN

# of Institutions

238

Shares Held

60M

Call Options Held

591K

Put Options Held

381K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.19B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Legend Biotech Corp Transaction History